Display options
Share it on

J Thorac Dis. 2015 Mar;7(3):439-48. doi: 10.3978/j.issn.2072-1439.2015.01.33.

Utility of EBUS-TBNA for diagnosis of mediastinal tuberculous lymphadenitis: a multicentre Australian experience.

Journal of thoracic disease

James Geake, Gary Hammerschlag, Phan Nguyen, Peter Wallbridge, Grant A Jenkin, Tony M Korman, Barton Jennings, Douglas F Johnson, Louis B Irving, Michael Farmer, Daniel P Steinfort

Affiliations

  1. 1 Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Brisbane 4032, Australia ; 2 Department Respiratory Medicine, The Royal Melbourne Hospital, Parkville 3050, Australia ; 3 Department of Thoracic Medicine, The Royal Adelaide Hospital, Adelaide 5000, Australia ; 4 Department of Infectious Diseases, Austin Hospital, Heidelberg 3084, Australia ; 5 Department of Infectious Diseases, 6 Monash Lung and Sleep, Monash Medical Centre, Clayton 3168, Australia ; 7 Department of Medicine, University of Melbourne, Parkville 3010, Australia.

PMID: 25922723 PMCID: PMC4387413 DOI: 10.3978/j.issn.2072-1439.2015.01.33

Abstract

BACKGROUND: Endobronchial ultrasound (EBUS) transbronchial needle aspiration (TBNA) is an important diagnostic procedure for the interrogation of mediastinal lymph nodes. There is limited data describing the accuracy & safety of this technique for the diagnosis of tuberculous mediastinal lymphadenitis.

METHODS: A multi-centre retrospective study of all EBUS-guided TBNA procedures that referred samples for mycobacteriology was performed. Results were correlated with post-procedural diagnoses after a period of surveillance and cross-checked against relevant statewide tuberculosis (TB) registries, and sensitivity and specificity was calculated. In addition, nucleic acid amplification techniques (NAAT) were assessed, and sensitivity and specificity calculated using positive mycobacterial culture as the reference gold standard.

RESULTS: One hundred and fifty-nine patients underwent EBUS-TBNA and had tissue referred for mycobacterial culture, of which 158 were included in the final analysis. Thirty-nine were ultimately diagnosed with TB (25%). Sensitivity of EBUS-TBNA for microbiologically confirmed tuberculous mediastinal lymphadenitis was 62% (24/39 cases). Specificity was 100%. Negative predictive value (NPV) and diagnostic accuracy for microbiologic diagnosis was 89% [95% confidence intervals (CI), 82-93%] and 91% (95% CI, 84-94%) respectively. For a composite clinicopathologic diagnosis of TB NPV and accuracy were 98% (95% CI, 93-99%) and 98% (95% CI, 95-99%) respectively. Sensitivity for NAAT was 38% (95% CI, 18-65%).

CONCLUSIONS: EBUS-TBNA is a safe and well tolerated procedure in the assessment of patients with suspected isolated mediastinal lymphadenitis and demonstrates good sensitivity for a microbiologic diagnosis of isolated mediastinal lymphadenitis. When culture and histological results are combined with high clinical suspicion, EBUS-TBNA demonstrates excellent diagnostic accuracy and NPV for the diagnosis of mediastinal TB lymphadenitis. We suggest EBUS-TBNA should be considered the procedure of choice for patients in whom TB is suspected.

Keywords: Endobronchial ultrasound (EBUS); PCR; bronchoscopy; culture; minimally invasive; mycobacteria; tuberculosis (TB)

References

  1. J Thorac Cardiovasc Surg. 1999 Nov;118(5):894-9 - PubMed
  2. Ann Thorac Surg. 2011 Mar;91(3):831-6 - PubMed
  3. J Clin Microbiol. 2011 Mar;49(3):1137-9 - PubMed
  4. Eur Respir J. 2010 Jun;35(6):1329-35 - PubMed
  5. Intern Med J. 2011 Dec;41(12 ):815-24 - PubMed
  6. J Clin Microbiol. 1995 Jul;33(7):1856-9 - PubMed
  7. Eur J Surg. 2001 May;167(5):334-8 - PubMed
  8. J Thorac Oncol. 2008 Jun;3(6):577-82 - PubMed
  9. J Infect Dev Ctries. 2012 Jan 12;6(1):6-12 - PubMed
  10. J Bronchology Interv Pulmonol. 2014 Jul;21(3):208-14 - PubMed
  11. Chest. 1998 Jan;113(1):147-53 - PubMed
  12. Ann Acad Med Singapore. 2014 May;43(5):250-4 - PubMed
  13. Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):287-93 - PubMed
  14. Eur Respir J. 2012 Sep;40(3):699-705 - PubMed
  15. Chest. 1997 Jul;112(1):251-3 - PubMed
  16. Ann Intern Med. 2008 Mar 4;148(5):325-36 - PubMed
  17. Eur J Cardiothorac Surg. 1998 Feb;13(2):196-9 - PubMed
  18. Eur Respir J. 2009 May;33(5):1156-64 - PubMed
  19. J Infect Dev Ctries. 2012 Jan 12;6(1):53-7 - PubMed
  20. N Engl J Med. 2004 May 13;350(20):2060-7 - PubMed
  21. J Clin Microbiol. 2011 Apr;49(4):1202-5 - PubMed
  22. Endoscopy. 2011 Nov;43(11):955-61 - PubMed
  23. J Microbiol Immunol Infect. 2009 Jun;42(3):251-7 - PubMed
  24. Thorax. 2012 Jul;67(7):650; author reply 652 - PubMed
  25. J Thorac Oncol. 2010 Oct;5(10 ):1564-70 - PubMed
  26. Chest. 2004 Feb;125(2):532-40 - PubMed
  27. J Thorac Cardiovasc Surg. 2011 Dec;142(6):1393-400.e1 - PubMed
  28. Chest. 2004 Jul;126(1):259-67 - PubMed
  29. J Infect. 2009 Apr;58(4):309-11 - PubMed
  30. N Engl J Med. 2014 May 1;370(18):1712-23 - PubMed
  31. Gastrointest Endosc. 2012 May;75(5):1005-10 - PubMed
  32. Ann Thorac Surg. 2013 Dec;96(6):2021-7 - PubMed
  33. Thorax. 1985 Feb;40(2):121-4 - PubMed
  34. J Clin Microbiol. 2011 Apr;49(4):1621-3 - PubMed
  35. Intern Med J. 2012 Sep;42(9):1029-36 - PubMed
  36. J Formos Med Assoc. 2014 Aug;113(8):527-34 - PubMed
  37. Thorax. 2011 Oct;66(10 ):889-93 - PubMed
  38. J Bronchology Interv Pulmonol. 2014 Apr;21(2):117-22 - PubMed
  39. BMC Infect Dis. 2012 Jun 22;12:141 - PubMed
  40. Chest. 2004 Feb;125(2):527-31 - PubMed
  41. Clin Infect Dis. 2012 Aug;55(3):313-21 - PubMed
  42. Ann Am Thorac Soc. 2014 Mar;11(3):392-6 - PubMed
  43. FEMS Immunol Med Microbiol. 2012 Oct;66(1):20-36 - PubMed
  44. ORL J Otorhinolaryngol Relat Spec. 1992;54(5):275-7 - PubMed
  45. J Investig Med. 2014 Aug;62(6):885-9 - PubMed
  46. Chest. 2007 Jun;131(6):1783-7 - PubMed

Publication Types